Skip to content

Effect of topical herbal cream on Eczema and it’s comparison with Mometasone 0.1%

Clinical trial of efficacy of a herbal cream containing Fumaria officinalis and Silybum marianum in the treatment of eczema; Double-blind controled Trial.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20181026041466N5
Enrollment
66
Registered
2020-09-27
Start date
2020-10-06
Completion date
Unknown
Last updated
2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eczema. Atopic dermatitis

Interventions

Intervention 1: Intervention group: The group receiving the herbal cream made by a researcher at the Ahvaz pharmacy School in Iran, every night until healing. Intervention 2: Control group: The group

Sponsors

Rayka raya teb co
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 70 Years

Inclusion criteria

Inclusion criteria: 18 years old Men and women or older One or more eczema lesions Patients who have not received topical, oral, or injectable medication for the treatment of eczema in the last week Lack of infection or malignancy at the treatment site (no problem with closed wounds) Patient's consent to participate in the study

Exclusion criteria

Exclusion criteria: Under 12 years old Pregnancy and lactation Patients with other skin lesions Patients taking immunosuppressive systemic drugs or biological drugs

Design outcomes

Primary

MeasureTime frame
Atopic dermatitis disease intensity. Timepoint: At the beginning of the study and about 30 days after starting the topical cream (after treatment). Method of measurement: SCORAD Index form.;Duration of recovery. Timepoint: About 30 days after starting the topical cream (after treatment). Method of measurement: Patient Tracking and Evaluation with SCORAD and DLQI.

Secondary

MeasureTime frame
Quality of dermatology patient's life. Timepoint: At the beginning of the study and about 30 days after starting the topical cream (after treatment). Method of measurement: DLQI questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli ??Aghaei

Ahvaz University of Medical Sciences

Ali.Aghaei110@gmail.com+98 916 100 1172

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026